Loading…

Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice

To investigate the therapeutical use of phage mixture for controlling gastrointestinal Escherichia coli O157:H7 cells, in vitro and in vivo experiments were conducted. Three phages, SP15, SP21, and SP22 were selected from 26 phage stock screened from feces of stock animals and sewage influent. Addit...

Full description

Saved in:
Bibliographic Details
Published in:Journal of bioscience and bioengineering 2005-09, Vol.100 (3), p.280-287
Main Authors: Tanji, Yasunori, Shimada, Takuya, Fukudomi, Hiroshi, Miyanaga, Kazuhiko, Nakai, Yutaka, Unno, Hajime
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c575t-c3286f87c67a5f25085d36ef7b7557022a502102f9a8e5f65ce558a10e4e68253
cites cdi_FETCH-LOGICAL-c575t-c3286f87c67a5f25085d36ef7b7557022a502102f9a8e5f65ce558a10e4e68253
container_end_page 287
container_issue 3
container_start_page 280
container_title Journal of bioscience and bioengineering
container_volume 100
creator Tanji, Yasunori
Shimada, Takuya
Fukudomi, Hiroshi
Miyanaga, Kazuhiko
Nakai, Yutaka
Unno, Hajime
description To investigate the therapeutical use of phage mixture for controlling gastrointestinal Escherichia coli O157:H7 cells, in vitro and in vivo experiments were conducted. Three phages, SP15, SP21, and SP22 were selected from 26 phage stock screened from feces of stock animals and sewage influent. Addition of single or binary phage to the E. coli cell batch-culture reduced the turbidity of the culture. However, reascend of the turbidity due to the appearance of phage resistance cell was observed. On the other hand, addition of three phage mixture (SP15-21-22) did not produce reascend of culture turbidity under aerobic condition. Under anaerobic condition, slight reascend of culture turbidity was observed after SP15-21-22 addition. Chemostat continuous culture was operated under anaerobic condition to optimize the titer of phage cocktail and frequency of the addition for controlling E. coli cells. Five-log decrease of E. coli cell concentration after addition of phage cocktail of 10 9 Plaque forming unit (PFU)/ml was observed. However, reascend of cell concentration was observed after 1 d incubation. Repeated addition of phage cocktail was effective to reduce the cell concentration. Suspension of phage cocktail in the buffer containing 0.25% CaCO 3 neutralized 9 times much more buffer of pH 2. Based on this in vitro experiment, phage cocktail (SP15-21-22) suspended in the buffer containing 0.25% CaCO 3 was orally administrated to the mice in which E. coli O157:H7 cells was administrated in 2-d advance. E. coli and phage concentration in the feces was monitored for 9 d after phage addition. High titer of phage was detected in the feces when the phage cocktail administrated daily. E. coli O157:H7 concentration in the feces has been reduced according to the time period. However, difference of E. coli concentration in the feces of mice administrates with phage and in the control mice without phage addition became slight after 9-d test period. High titer of the phage settled down in the gastrointestinal tracts and reduced the concentration of E. coli cell. Repeated oral administration of SP15-21-22 was effective for rapid evacuation of E. coli O157:H7 from the feces and gastrointestinal tract of mice.
doi_str_mv 10.1263/jbb.100.280
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68719772</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1389172305704667</els_id><sourcerecordid>20857482</sourcerecordid><originalsourceid>FETCH-LOGICAL-c575t-c3286f87c67a5f25085d36ef7b7557022a502102f9a8e5f65ce558a10e4e68253</originalsourceid><addsrcrecordid>eNqFkc1vEzEQxS0EoqVw4gzyBS5ow9i7_khvqCoUVKkcytmaOOPExVkHexeJ_x5HidQLEiePPT-_Gb3H2GsBCyF1__FhtVoIgIW08ISdi34w3TBI8fRQ22UnjOzP2ItaHwCEASOeszOh5dBLY85Zut9SwT3NU_R8rsRz4Pstboj77H9OGBMPubTLOJWcUhw3_Lr69if6bcT2niK_E8pc3hgeR77B2rg4TlSnOGLiU0E_HUR30dNL9ixgqvTqdF6wH5-v769uutu7L1-vPt12Xhk1db6XVgdrvDaoglRg1brXFMzKKGVASlQgBciwREsqaOVJKYsCaCBtpeov2Puj7r7kX3Nbxe1i9ZQSjpTn6rQ1YmmaL_8DZRttBnsAPxxBX3KthYLbl7jD8scJcIcUXEuh1eBaCo1-e5KdVztaP7In2xvw7gRg9ZhCwdHH-sgZofulFo17c-QCZoeb0phv3yWABuhB2tZXxz41N39HKq76SKOndSzkJ7fO8Z8L_gWDe6lA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>20857482</pqid></control><display><type>article</type><title>Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice</title><source>Elsevier</source><creator>Tanji, Yasunori ; Shimada, Takuya ; Fukudomi, Hiroshi ; Miyanaga, Kazuhiko ; Nakai, Yutaka ; Unno, Hajime</creator><creatorcontrib>Tanji, Yasunori ; Shimada, Takuya ; Fukudomi, Hiroshi ; Miyanaga, Kazuhiko ; Nakai, Yutaka ; Unno, Hajime</creatorcontrib><description>To investigate the therapeutical use of phage mixture for controlling gastrointestinal Escherichia coli O157:H7 cells, in vitro and in vivo experiments were conducted. Three phages, SP15, SP21, and SP22 were selected from 26 phage stock screened from feces of stock animals and sewage influent. Addition of single or binary phage to the E. coli cell batch-culture reduced the turbidity of the culture. However, reascend of the turbidity due to the appearance of phage resistance cell was observed. On the other hand, addition of three phage mixture (SP15-21-22) did not produce reascend of culture turbidity under aerobic condition. Under anaerobic condition, slight reascend of culture turbidity was observed after SP15-21-22 addition. Chemostat continuous culture was operated under anaerobic condition to optimize the titer of phage cocktail and frequency of the addition for controlling E. coli cells. Five-log decrease of E. coli cell concentration after addition of phage cocktail of 10 9 Plaque forming unit (PFU)/ml was observed. However, reascend of cell concentration was observed after 1 d incubation. Repeated addition of phage cocktail was effective to reduce the cell concentration. Suspension of phage cocktail in the buffer containing 0.25% CaCO 3 neutralized 9 times much more buffer of pH 2. Based on this in vitro experiment, phage cocktail (SP15-21-22) suspended in the buffer containing 0.25% CaCO 3 was orally administrated to the mice in which E. coli O157:H7 cells was administrated in 2-d advance. E. coli and phage concentration in the feces was monitored for 9 d after phage addition. High titer of phage was detected in the feces when the phage cocktail administrated daily. E. coli O157:H7 concentration in the feces has been reduced according to the time period. However, difference of E. coli concentration in the feces of mice administrates with phage and in the control mice without phage addition became slight after 9-d test period. High titer of the phage settled down in the gastrointestinal tracts and reduced the concentration of E. coli cell. Repeated oral administration of SP15-21-22 was effective for rapid evacuation of E. coli O157:H7 from the feces and gastrointestinal tract of mice.</description><identifier>ISSN: 1389-1723</identifier><identifier>EISSN: 1347-4421</identifier><identifier>DOI: 10.1263/jbb.100.280</identifier><identifier>PMID: 16243277</identifier><language>eng</language><publisher>Amsterdarm: Elsevier B.V</publisher><subject>Administration, Oral ; AGENT PATHOGENE ; Animals ; BACTERIOFAGOS ; Bacteriolysis ; BACTERIOPHAGE ; BACTERIOPHAGES ; Biological and medical sciences ; Biotechnology ; Cattle ; Cell Count ; Coliphages - isolation &amp; purification ; DRUGS ; ESCHERICHIA COLI ; Escherichia coli Infections - therapy ; Escherichia coli O157 - virology ; Escherichia coli O157:H7 ; Feces - virology ; Fundamental and applied biological sciences. Psychology ; Gastrointestinal Tract - microbiology ; MEDICAMENT ; MEDICAMENTOS ; Mice ; ORGANISMOS PATOGENOS ; PATHOGENS ; Phage sp15 ; Probiotics - administration &amp; dosage ; Probiotics - therapeutic use</subject><ispartof>Journal of bioscience and bioengineering, 2005-09, Vol.100 (3), p.280-287</ispartof><rights>2005 The Society for Biotechnology, Japan</rights><rights>2005 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c575t-c3286f87c67a5f25085d36ef7b7557022a502102f9a8e5f65ce558a10e4e68253</citedby><cites>FETCH-LOGICAL-c575t-c3286f87c67a5f25085d36ef7b7557022a502102f9a8e5f65ce558a10e4e68253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=17163961$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16243277$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Tanji, Yasunori</creatorcontrib><creatorcontrib>Shimada, Takuya</creatorcontrib><creatorcontrib>Fukudomi, Hiroshi</creatorcontrib><creatorcontrib>Miyanaga, Kazuhiko</creatorcontrib><creatorcontrib>Nakai, Yutaka</creatorcontrib><creatorcontrib>Unno, Hajime</creatorcontrib><title>Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice</title><title>Journal of bioscience and bioengineering</title><addtitle>J Biosci Bioeng</addtitle><description>To investigate the therapeutical use of phage mixture for controlling gastrointestinal Escherichia coli O157:H7 cells, in vitro and in vivo experiments were conducted. Three phages, SP15, SP21, and SP22 were selected from 26 phage stock screened from feces of stock animals and sewage influent. Addition of single or binary phage to the E. coli cell batch-culture reduced the turbidity of the culture. However, reascend of the turbidity due to the appearance of phage resistance cell was observed. On the other hand, addition of three phage mixture (SP15-21-22) did not produce reascend of culture turbidity under aerobic condition. Under anaerobic condition, slight reascend of culture turbidity was observed after SP15-21-22 addition. Chemostat continuous culture was operated under anaerobic condition to optimize the titer of phage cocktail and frequency of the addition for controlling E. coli cells. Five-log decrease of E. coli cell concentration after addition of phage cocktail of 10 9 Plaque forming unit (PFU)/ml was observed. However, reascend of cell concentration was observed after 1 d incubation. Repeated addition of phage cocktail was effective to reduce the cell concentration. Suspension of phage cocktail in the buffer containing 0.25% CaCO 3 neutralized 9 times much more buffer of pH 2. Based on this in vitro experiment, phage cocktail (SP15-21-22) suspended in the buffer containing 0.25% CaCO 3 was orally administrated to the mice in which E. coli O157:H7 cells was administrated in 2-d advance. E. coli and phage concentration in the feces was monitored for 9 d after phage addition. High titer of phage was detected in the feces when the phage cocktail administrated daily. E. coli O157:H7 concentration in the feces has been reduced according to the time period. However, difference of E. coli concentration in the feces of mice administrates with phage and in the control mice without phage addition became slight after 9-d test period. High titer of the phage settled down in the gastrointestinal tracts and reduced the concentration of E. coli cell. Repeated oral administration of SP15-21-22 was effective for rapid evacuation of E. coli O157:H7 from the feces and gastrointestinal tract of mice.</description><subject>Administration, Oral</subject><subject>AGENT PATHOGENE</subject><subject>Animals</subject><subject>BACTERIOFAGOS</subject><subject>Bacteriolysis</subject><subject>BACTERIOPHAGE</subject><subject>BACTERIOPHAGES</subject><subject>Biological and medical sciences</subject><subject>Biotechnology</subject><subject>Cattle</subject><subject>Cell Count</subject><subject>Coliphages - isolation &amp; purification</subject><subject>DRUGS</subject><subject>ESCHERICHIA COLI</subject><subject>Escherichia coli Infections - therapy</subject><subject>Escherichia coli O157 - virology</subject><subject>Escherichia coli O157:H7</subject><subject>Feces - virology</subject><subject>Fundamental and applied biological sciences. Psychology</subject><subject>Gastrointestinal Tract - microbiology</subject><subject>MEDICAMENT</subject><subject>MEDICAMENTOS</subject><subject>Mice</subject><subject>ORGANISMOS PATOGENOS</subject><subject>PATHOGENS</subject><subject>Phage sp15</subject><subject>Probiotics - administration &amp; dosage</subject><subject>Probiotics - therapeutic use</subject><issn>1389-1723</issn><issn>1347-4421</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNqFkc1vEzEQxS0EoqVw4gzyBS5ow9i7_khvqCoUVKkcytmaOOPExVkHexeJ_x5HidQLEiePPT-_Gb3H2GsBCyF1__FhtVoIgIW08ISdi34w3TBI8fRQ22UnjOzP2ItaHwCEASOeszOh5dBLY85Zut9SwT3NU_R8rsRz4Pstboj77H9OGBMPubTLOJWcUhw3_Lr69if6bcT2niK_E8pc3hgeR77B2rg4TlSnOGLiU0E_HUR30dNL9ixgqvTqdF6wH5-v769uutu7L1-vPt12Xhk1db6XVgdrvDaoglRg1brXFMzKKGVASlQgBciwREsqaOVJKYsCaCBtpeov2Puj7r7kX3Nbxe1i9ZQSjpTn6rQ1YmmaL_8DZRttBnsAPxxBX3KthYLbl7jD8scJcIcUXEuh1eBaCo1-e5KdVztaP7In2xvw7gRg9ZhCwdHH-sgZofulFo17c-QCZoeb0phv3yWABuhB2tZXxz41N39HKq76SKOndSzkJ7fO8Z8L_gWDe6lA</recordid><startdate>20050901</startdate><enddate>20050901</enddate><creator>Tanji, Yasunori</creator><creator>Shimada, Takuya</creator><creator>Fukudomi, Hiroshi</creator><creator>Miyanaga, Kazuhiko</creator><creator>Nakai, Yutaka</creator><creator>Unno, Hajime</creator><general>Elsevier B.V</general><general>Elsevier Science</general><scope>FBQ</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>7X8</scope></search><sort><creationdate>20050901</creationdate><title>Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice</title><author>Tanji, Yasunori ; Shimada, Takuya ; Fukudomi, Hiroshi ; Miyanaga, Kazuhiko ; Nakai, Yutaka ; Unno, Hajime</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c575t-c3286f87c67a5f25085d36ef7b7557022a502102f9a8e5f65ce558a10e4e68253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Administration, Oral</topic><topic>AGENT PATHOGENE</topic><topic>Animals</topic><topic>BACTERIOFAGOS</topic><topic>Bacteriolysis</topic><topic>BACTERIOPHAGE</topic><topic>BACTERIOPHAGES</topic><topic>Biological and medical sciences</topic><topic>Biotechnology</topic><topic>Cattle</topic><topic>Cell Count</topic><topic>Coliphages - isolation &amp; purification</topic><topic>DRUGS</topic><topic>ESCHERICHIA COLI</topic><topic>Escherichia coli Infections - therapy</topic><topic>Escherichia coli O157 - virology</topic><topic>Escherichia coli O157:H7</topic><topic>Feces - virology</topic><topic>Fundamental and applied biological sciences. Psychology</topic><topic>Gastrointestinal Tract - microbiology</topic><topic>MEDICAMENT</topic><topic>MEDICAMENTOS</topic><topic>Mice</topic><topic>ORGANISMOS PATOGENOS</topic><topic>PATHOGENS</topic><topic>Phage sp15</topic><topic>Probiotics - administration &amp; dosage</topic><topic>Probiotics - therapeutic use</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Tanji, Yasunori</creatorcontrib><creatorcontrib>Shimada, Takuya</creatorcontrib><creatorcontrib>Fukudomi, Hiroshi</creatorcontrib><creatorcontrib>Miyanaga, Kazuhiko</creatorcontrib><creatorcontrib>Nakai, Yutaka</creatorcontrib><creatorcontrib>Unno, Hajime</creatorcontrib><collection>AGRIS</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of bioscience and bioengineering</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Tanji, Yasunori</au><au>Shimada, Takuya</au><au>Fukudomi, Hiroshi</au><au>Miyanaga, Kazuhiko</au><au>Nakai, Yutaka</au><au>Unno, Hajime</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice</atitle><jtitle>Journal of bioscience and bioengineering</jtitle><addtitle>J Biosci Bioeng</addtitle><date>2005-09-01</date><risdate>2005</risdate><volume>100</volume><issue>3</issue><spage>280</spage><epage>287</epage><pages>280-287</pages><issn>1389-1723</issn><eissn>1347-4421</eissn><abstract>To investigate the therapeutical use of phage mixture for controlling gastrointestinal Escherichia coli O157:H7 cells, in vitro and in vivo experiments were conducted. Three phages, SP15, SP21, and SP22 were selected from 26 phage stock screened from feces of stock animals and sewage influent. Addition of single or binary phage to the E. coli cell batch-culture reduced the turbidity of the culture. However, reascend of the turbidity due to the appearance of phage resistance cell was observed. On the other hand, addition of three phage mixture (SP15-21-22) did not produce reascend of culture turbidity under aerobic condition. Under anaerobic condition, slight reascend of culture turbidity was observed after SP15-21-22 addition. Chemostat continuous culture was operated under anaerobic condition to optimize the titer of phage cocktail and frequency of the addition for controlling E. coli cells. Five-log decrease of E. coli cell concentration after addition of phage cocktail of 10 9 Plaque forming unit (PFU)/ml was observed. However, reascend of cell concentration was observed after 1 d incubation. Repeated addition of phage cocktail was effective to reduce the cell concentration. Suspension of phage cocktail in the buffer containing 0.25% CaCO 3 neutralized 9 times much more buffer of pH 2. Based on this in vitro experiment, phage cocktail (SP15-21-22) suspended in the buffer containing 0.25% CaCO 3 was orally administrated to the mice in which E. coli O157:H7 cells was administrated in 2-d advance. E. coli and phage concentration in the feces was monitored for 9 d after phage addition. High titer of phage was detected in the feces when the phage cocktail administrated daily. E. coli O157:H7 concentration in the feces has been reduced according to the time period. However, difference of E. coli concentration in the feces of mice administrates with phage and in the control mice without phage addition became slight after 9-d test period. High titer of the phage settled down in the gastrointestinal tracts and reduced the concentration of E. coli cell. Repeated oral administration of SP15-21-22 was effective for rapid evacuation of E. coli O157:H7 from the feces and gastrointestinal tract of mice.</abstract><cop>Amsterdarm</cop><pub>Elsevier B.V</pub><pmid>16243277</pmid><doi>10.1263/jbb.100.280</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1389-1723
ispartof Journal of bioscience and bioengineering, 2005-09, Vol.100 (3), p.280-287
issn 1389-1723
1347-4421
language eng
recordid cdi_proquest_miscellaneous_68719772
source Elsevier
subjects Administration, Oral
AGENT PATHOGENE
Animals
BACTERIOFAGOS
Bacteriolysis
BACTERIOPHAGE
BACTERIOPHAGES
Biological and medical sciences
Biotechnology
Cattle
Cell Count
Coliphages - isolation & purification
DRUGS
ESCHERICHIA COLI
Escherichia coli Infections - therapy
Escherichia coli O157 - virology
Escherichia coli O157:H7
Feces - virology
Fundamental and applied biological sciences. Psychology
Gastrointestinal Tract - microbiology
MEDICAMENT
MEDICAMENTOS
Mice
ORGANISMOS PATOGENOS
PATHOGENS
Phage sp15
Probiotics - administration & dosage
Probiotics - therapeutic use
title Therapeutic use of phage cocktail for controlling Escherichia coli O157:H7 in gastrointestinal tract of mice
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T18%3A49%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Therapeutic%20use%20of%20phage%20cocktail%20for%20controlling%20Escherichia%20coli%20O157:H7%20in%20gastrointestinal%20tract%20of%20mice&rft.jtitle=Journal%20of%20bioscience%20and%20bioengineering&rft.au=Tanji,%20Yasunori&rft.date=2005-09-01&rft.volume=100&rft.issue=3&rft.spage=280&rft.epage=287&rft.pages=280-287&rft.issn=1389-1723&rft.eissn=1347-4421&rft_id=info:doi/10.1263/jbb.100.280&rft_dat=%3Cproquest_cross%3E20857482%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c575t-c3286f87c67a5f25085d36ef7b7557022a502102f9a8e5f65ce558a10e4e68253%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=20857482&rft_id=info:pmid/16243277&rfr_iscdi=true